Diagnostic Performance and Safety of ¹⁸F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply

Affiliations

• ¹ Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
• ² Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
• ³ Montefiore Medical Center, Bronx, New York.
• ⁴ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, WashingtonUniversity School of Medicine, St Louis, Missouri.
• ⁵ Saint John's Cancer Institute, Santa Monica, California.
• ⁶ Urology San Antonio, San Antonio, Texas.
• ⁷ Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia.
• ⁸ Blue Earth Diagnostics Ltd, Oxford, UK.
• ⁹ Blue Earth Diagnostics, Inc, Monroe Township, New Jersey.
• ¹⁰ Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
• ¹¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.